<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82130">
  <stage>Registered</stage>
  <submitdate>2/07/2007</submitdate>
  <approvaldate>10/04/2008</approvaldate>
  <actrnumber>ACTRN12608000181303</actrnumber>
  <trial_identification>
    <studytitle>Detection of recombinant human luteinising hormone (rLH) as a doping agent</studytitle>
    <scientifictitle>Detection of recombinant human luteinising hormone as a doping agent in healthy male volunteers aged 18 to 45. An open label, randomised clinical study.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Sports doping detection</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Normal metabolism and endocrine development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Half of the participants will have a 200mg injection of Nandrolone decanoate, then 3 days later a single dose of rLH 
75IU or 225IU or recombinant human chorionic gonadotropin 'rhCG' 250ug or 750ug . Those given 'rhCG' will have another 100mg dose of Nandrolone decanoate the following day. The other half of the participants will be given either a single dose of either rLH 75IU or 225IU or rhCG 250ug or 750ug without the Nandrolone.  Blood and urine samples will be obtained at intervals form 0 for up to 8 days.</interventions>
    <comparator>Acting as their own controls, baseline blood and urine samples taken to measure against post treatment samples.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Bioassay measurement of LH levels in blood and urine samples</outcome>
      <timepoint>Samples of blood and urine taken at baseline and at intervals for 8 days</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Bioassay measurement of testosterone in blood and urine samples</outcome>
      <timepoint>Samples of blood and urine taken at baseline and at intervals for 8 days</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>None</outcome>
      <timepoint>Not applicable</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy males</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>No recent history of steriod use</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>permuted block randomisation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics / pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>23/11/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>64</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2139</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Sydney South Western Area Health Service (SSWAHS)</primarysponsorname>
    <primarysponsoraddress>Concord Repatriation General Hospital
Hospital Road
Concord NSW  2139</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>World Anti Doping Agency (WADA)</fundingname>
      <fundingaddress>Montreal Canada</fundingaddress>
      <fundingcountry>Canada</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Sports anti-doping study</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Concord Hospital HREC</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec>CH62/6/2004-110-D Handelsman</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Concord Repatriation General Hospital (CRGH)</ethicname>
      <ethicaddress>Hospital Road
Concord
NSW 2137</ethicaddress>
      <ethicapprovaldate>24/02/2005</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>2/11/2004</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>D J Handelsman</name>
      <address>Anzac Research Institute
Hospital Road
Concord NSW 2139</address>
      <phone>02 9767 7222</phone>
      <fax>02 9767 7221</fax>
      <email>djh@anzac.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>D J Handelsman</name>
      <address>Anzac Research Institute
Hospital Road
Concord NSW 2139</address>
      <phone>02 9767 7222</phone>
      <fax>02 9767 7221</fax>
      <email>djh@anzac.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>D J Handelsman</name>
      <address>Anzac Research Institute</address>
      <phone>02 97679100</phone>
      <fax />
      <email>djh@anzac.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>